← Insider Monitor
HEPA
Hepion Pharmaceuticals, Inc.
Recent activity from public SEC and congressional filings.
6
Insider trades
0
Congress trades
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| LoPriore Vincent SExecutive Chairman | Buy | $400K | 8,000,000at $0.05 | Aug 3, 2026 |
| Stetz Gary S.Interim CEO | Buy | $100K | 2,000,000at $0.05 | Aug 3, 2026 |
| Purcell Michael J.Director | Buy | $100K | 2,000,000at $0.05 | Aug 3, 2026 |
| Appajosyula SireeshChief Operating Officer | Buy | $100K | 2,000,000at $0.05 | Aug 3, 2026 |
| LoPriore Vincent SExecutive Chairman | Buy | $100K | 2,000,000at $0.05 | Aug 3, 2026 |
| Stetz Gary S. IIDirector | Buy | $25K | 500,000at $0.05 | Aug 3, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
No recent congressional disclosures found for HEPA.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable HEPA activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.